ID OREX_RAT Reviewed; 130 AA. AC O55232; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1998, sequence version 1. DT 16-JUN-2009, entry version 66. DE RecName: Full=Orexin; DE AltName: Full=Hypocretin; DE Short=Hcrt; DE Contains: DE RecName: Full=Orexin-A; DE AltName: Full=Hypocretin-1; DE Short=Hcrt1; DE Contains: DE RecName: Full=Orexin-B; DE AltName: Full=Hypocretin-2; DE Short=Hcrt2; DE Flags: Precursor; GN Name=Hcrt; Synonyms=Ox, Ppox; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 33-65 AND 69-96, AND RP MASS SPECTROMETRY. RC TISSUE=Brain; RX MEDLINE=98150861; PubMed=9491897; DOI=10.1016/S0092-8674(00)80949-6; RA Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., RA Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., RA Arch J.R.S., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., RA McNulty D.E., Liu W.-S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., RA Yanagisawa M.; RT "Orexins and orexin receptors: a family of hypothalamic neuropeptides RT and G protein-coupled receptors that regulate feeding behavior."; RL Cell 92:573-585(1998). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=Sprague-Dawley; RX MEDLINE=98081872; PubMed=9419374; DOI=10.1073/pnas.95.1.322; RA de Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., RA Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., RA Bartlett F.S. II, Frankel W.N., van den Pol A.N., Bloom F.E., RA Gautvik K.M., Sutcliffe J.G.; RT "The hypocretins: hypothalamus-specific peptides with neuroexcitatory RT activity."; RL Proc. Natl. Acad. Sci. U.S.A. 95:322-327(1998). RN [3] RP REVIEW. RX MEDLINE=21237974; PubMed=11340621; DOI=10.1002/bies.1058; RA Hungs M., Mignot E.; RT "Hypocretin/orexin, sleep and narcolepsy."; RL Bioessays 23:397-408(2001). RN [4] RP REVIEW. RX MEDLINE=21178476; PubMed=11283317; DOI=10.1146/annurev.neuro.24.1.429; RA Willie J.T., Chemelli R.M., Sinton C.M., Yanagisawa M.; RT "To eat or to sleep? Orexin in the regulation of feeding and RT wakefulness."; RL Annu. Rev. Neurosci. 24:429-458(2001). CC -!- FUNCTION: Neuropeptides that play a significant role in the CC regulation of food intake and sleep-wakefulness, possibly by CC coordinating the complex behavioral and physiologic responses of CC these complementary homeostatic functions. A broader role in the CC homeostatic regulation of energy metabolism, autonomic function, CC hormonal balance and the regulation of body fluids, is also CC suggested. A modulation effect on luteinizing hormone-releasing CC hormone (LHRH) secretion also suggests a more minor contribution CC to the regulation of reproductive function. Orexin-A binds to both CC OX1R and OX2R with a high affinity, whereas orexin-B binds only to CC OX2R with a similar high affinity. CC -!- SUBCELLULAR LOCATION: Rough endoplasmic reticulum. Note=Associated CC with perikaryal rough endoplasmic reticulum as well as cytoplasmic CC large granular vesicles at synapses. CC -!- TISSUE SPECIFICITY: Produced by a small group of neurons CC restricted to the lateral and posterior hypothalamus and CC perifornical areas. Positive neurons project widely throughout the CC entire neuroaxis. Particularly abundant projections in the CC cerebral cortex, olfactory bulb, hippocampus, amygdala, septum, CC diagonal band of Broca, bed nucleus of the stria terminalis, CC thalamus, anterior and posterior hypothalamus, midbrain, CC brainstem, and spinal cord. Immunoreactivity reported in the CC enteric nervous system and pancreas. In small amount, also CC detected in the testis. CC -!- DEVELOPMENTAL STAGE: Detected as early as embryonic day 18, but CC expression increased dramatically after the third postnatal week. CC -!- INDUCTION: By nutritional state, up-regulated by fasting, fluid CC deprivation and insulin-induced hypoglycemia. Orexin-A CC immunoreactivity varies diurnally and peaks during the dark phase, CC in the pons and the location of locus coeruleus. CC -!- PTM: Specific enzymatic cleavages at paired basic residues yield CC the different active peptides. CC -!- MASS SPECTROMETRY: Mass=3558.7; Mass_error=0.1; Method=MALDI; CC Range=33-65; Source=PubMed:9491897; CC -!- SIMILARITY: Belongs to the orexin family. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Qui dort dine - Issue CC 15 of October 2001; CC URL="http://www.expasy.org/spotlight/back_issues/sptlt015.shtml"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF041241; AAC40039.1; -; mRNA. DR EMBL; AF019565; AAC02933.1; -; mRNA. DR IPI; IPI00196788; -. DR RefSeq; NP_037311.1; -. DR UniGene; Rn.7628; -. DR Ensembl; ENSRNOG00000018892; Rattus norvegicus. DR GeneID; 25723; -. DR KEGG; rno:25723; -. DR RGD; 2786; Hcrt. DR HOVERGEN; O55232; -. DR OMA; O55232; PCPGRRC. DR NextBio; 607825; -. DR ArrayExpress; O55232; -. DR GermOnline; ENSRNOG00000018892; Rattus norvegicus. DR GO; GO:0005791; C:rough endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0030141; C:secretory granule; IDA:RGD. DR GO; GO:0005184; F:neuropeptide hormone activity; IDA:RGD. DR GO; GO:0031771; F:type 1 hypocretin receptor binding; IDA:RGD. DR GO; GO:0031772; F:type 2 hypocretin receptor binding; IDA:RGD. DR GO; GO:0007200; P:activation of phospholipase C activity by G...; IMP:RGD. DR GO; GO:0007205; P:activation of protein kinase C activity by ...; IMP:RGD. DR GO; GO:0001662; P:behavioral fear response; NAS:RGD. DR GO; GO:0042755; P:eating behavior; IDA:RGD. DR GO; GO:0007204; P:elevation of cytosolic calcium ion concentr...; IDA:RGD. DR GO; GO:0008156; P:negative regulation of DNA replication; IDA:RGD. DR GO; GO:0043267; P:negative regulation of potassium ion transport; IDA:RGD. DR GO; GO:0051970; P:negative regulation of transmission of nerv...; IDA:RGD. DR GO; GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW. DR GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:RGD. DR GO; GO:0051971; P:positive regulation of transmission of nerv...; IDA:RGD. DR GO; GO:0060079; P:regulation of excitatory postsynaptic membr...; IDA:RGD. DR GO; GO:0046928; P:regulation of neurotransmitter secretion; IDA:RGD. DR InterPro; IPR001704; Orexin. DR PANTHER; PTHR15173; Orexin; 1. DR Pfam; PF02072; Orexin; 1. DR PRINTS; PR01091; OREXINPP. PE 1: Evidence at protein level; KW Amidation; Cleavage on pair of basic residues; KW Direct protein sequencing; Disulfide bond; Endoplasmic reticulum; KW Neuropeptide; Pyrrolidone carboxylic acid; Signal. FT SIGNAL 1 32 FT PEPTIDE 33 65 Orexin-A. FT /FTId=PRO_0000020270. FT PEPTIDE 69 96 Orexin-B. FT /FTId=PRO_0000020271. FT PROPEP 97 130 FT /FTId=PRO_0000020272. FT MOD_RES 33 33 Pyrrolidone carboxylic acid. FT MOD_RES 65 65 Leucine amide. FT MOD_RES 96 96 Methionine amide. FT DISULFID 38 44 FT DISULFID 39 46 SQ SEQUENCE 130 AA; 13645 MW; 00CAB259EDF2A404 CRC64; MNLPSTKVPW AAVTLLLLLL LPPALLSLGV DAQPLPDCCR QKTCSCRLYE LLHGAGNHAA GILTLGKRRP GPPGLQGRLQ RLLQANGNHA AGILTMGRRA GAELEPYPCP GRRCPTATAT ALAPRGGSRV //